60 participants
Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-31
- Start Date:
- 2024-02-14
- Completion:
- 2027-07-01
Conditions
- Acute Lymphoblastic Leukemia, in Relapse
- Acute Lymphoblastic Leukemia, Refractory
- Pediatric ALL
Interventions
- BIOLOGICAL
- DRUG
- DEVICE
- PROCEDURE
No Results Yet